Lipes Barbara D, Chen Yu-Hsun, Ma Hongzheng, Staats Herman F, Kenan Daniel J, Gunn Michael Dee
Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
J Mol Biol. 2008 May 30;379(2):261-72. doi: 10.1016/j.jmb.2008.03.072. Epub 2008 Apr 7.
The generation of recombinant antibodies (Abs) using phage display is a proven method to obtain a large variety of Abs that bind with high affinity to a given antigen. Traditionally, the generation of single-chain Abs depends on the use of recombinant proteins in several stages of the procedure. This can be a problem, especially in the case of cell-surface receptors, because Abs generated and selected against recombinant proteins may not bind the same protein expressed on a cell surface in its native form and because the expression of some receptors as recombinant proteins is problematic. To overcome these difficulties, we developed a strategy to generate single-chain Abs that does not require the use of recombinant protein at any stage of the procedure. In this strategy, stably transfected cells are used for the immunization of mice, measuring Ab responses to immunization, panning the phage library, high-throughput screening of arrayed phage clones, and characterization of recombinant single-chain variable regions. This strategy was used to generate a panel of single-chain Abs specific for the innate immunity receptor Toll-like receptor 2. Once generated, individual single-chain variable regions were subcloned into an expression vector allowing the production of recombinant Abs in insect cells, thus avoiding the contamination of recombinant Abs with microbial products. This cell-based system efficiently generates Abs that bind to native molecules on the cell surface, bypasses the requirement of recombinant protein production, and avoids risks of microbial component contamination.
利用噬菌体展示技术生成重组抗体(Abs)是一种行之有效的方法,可获得大量能与特定抗原高亲和力结合的抗体。传统上,单链抗体的生成在该过程的几个阶段都依赖于重组蛋白的使用。这可能会成为一个问题,尤其是对于细胞表面受体而言,因为针对重组蛋白生成和筛选的抗体可能无法结合以天然形式表达在细胞表面的相同蛋白,而且某些受体作为重组蛋白进行表达也存在问题。为克服这些困难,我们开发了一种生成单链抗体的策略,该策略在过程的任何阶段都无需使用重组蛋白。在这种策略中,稳定转染的细胞用于免疫小鼠、测量免疫后的抗体反应、淘选噬菌体文库、对排列的噬菌体克隆进行高通量筛选以及对重组单链可变区进行表征。该策略用于生成一组针对天然免疫受体Toll样受体2的单链抗体。一旦生成,各个单链可变区被亚克隆到一个表达载体中,从而能够在昆虫细胞中生产重组抗体,进而避免重组抗体被微生物产物污染。这种基于细胞的系统能够高效生成与细胞表面天然分子结合的抗体,绕过了重组蛋白生产的需求,并避免了微生物成分污染的风险。